Plexium and Abbvie Enter into Multi-target Strategic Collaboration to Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions
April 28, 2022
The Column Group announces the promotion of Dr. Sarah Hymowitz from Venture Partner to Partner. Dr. Hymowitz has been with TCG since 2021.
Dr. Sarah Hymowitz Promoted from Venture Partner to Partner Read More »